Please assess the completion status of the following clinical trial:

Trial Title: Prehabilitation in Esophageal Surgery (PRESS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent;~* Patients scheduled for Esophageal cancer resection with Ivor-lewis technique;~* Previous CT/RT neoadjuvant treatment;~* Possibility to perform a prehabilitation treatment of, at least, 4 weeks.~Exclusion Criteria:~* Patient refusal~* Comorbid medical, physical, and mental conditions that contraindicate exercise or oral nutrition.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Prehabilitation program (Type: EXPERIMENTAL): The patients included in the treatment group will follow a prehabilitation program, based on a physiotherapist, nutritionist and psychologist evaluation. All the treatments will be tailored according the characteristics of each single patient. The program will have a duration of, at least, 4 weeks.
- Control (Type: NO_INTERVENTION): The patients included in this group will, also, receive a basal evaluation by a physiotherapist, a nutritionist and a psychologist. These patients will not receive a tailored prehabilitation program and will be revaluated the day before surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).